Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.

R Gomeni

    Computers in Biology and Medicine
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model-Informed Drug Discovery and Development.

    CPT: pharmacometrics & systems pharmacology·2017
    Same author

    Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.

    Clinical pharmacology and therapeutics·2017
    Same author

    The Effects of SENS-111, A New H4R Antagonist, On Vertigo Induced by Caloric Test in Healthy Volunteers (HV) is Related to Plasma Concentrations.

    Clinical therapeutics·2016
    Same author

    Use of Longitudinal Dose-Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE).

    CPT: pharmacometrics & systems pharmacology·2015
    Same author

    A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone.

    Journal of clinical pharmacology·2013
    Same author

    Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.

    Clinical drug investigation·2013

    A new computer program, PHARM, estimates pharmacokinetic parameters in nonlinear models. It aids in analyzing individual and population data, enhancing drug development research.

    Area of Science:

    • Pharmacokinetics and computational modeling.
    • Development of novel software for biological data analysis.

    Background:

    • Accurate estimation of pharmacokinetic parameters is crucial for drug development and personalized medicine.
    • Existing methods may lack flexibility in defining complex pharmacokinetic models and error structures.

    Purpose of the Study:

    • To introduce PHARM, a new interactive computer program for estimating pharmacokinetic parameters.
    • To provide a flexible tool for defining structural and error models in pharmacokinetic analysis.
    • To enable estimation of both individual and population pharmacokinetic parameters using advanced statistical methods.

    Main Methods:

    • Development of an interactive computer program (PHARM) with graphical capabilities.
    • Implementation of user-defined structural models using differential or integrated equations.

    Related Experiment Videos

  • Incorporation of user-defined error models for experimental data.
  • Application of the nonlinear mixed-effect model for population parameter estimation.
  • Utilization of maximum likelihood and Bayesian criteria for simultaneous parameter estimation.

    • Main Results:

    • PHARM facilitates the estimation of individual and population pharmacokinetic parameters within nonlinear models.
    • The program supports flexible model definition, including structural and error components.
    • Graphical facilities enhance data visualization and result interpretation.
    • Nonlinear mixed-effect modeling allows for the assessment of population mean parameters and interindividual variability.

    Conclusions:

    • PHARM offers a powerful and flexible computational tool for pharmacokinetic analysis.
    • The program supports advanced modeling techniques, including nonlinear mixed-effect models.
    • PHARM can aid researchers in a more precise understanding of drug behavior in populations and individuals.